Literature DB >> 23921925

Recurrent contralateral hearing loss after 2 craniotomies for vestibular schwannoma: etiologic implications.

Morgan Renee Bliss1, Robert K Jackler, Richard Klaus Gurgel.   

Abstract

OBJECTIVE: To describe recurrent sudden sensorineural hearing loss after contralateral vestibular schwannoma resection and re-resection. STUDY
DESIGN: Clinical capsule report.
SETTING: Tertiary academic referral hospital. PATIENT: A patient who underwent 2 craniotomies for vestibular schwannoma.
RESULTS: In 2003, a patient experienced contralateral low-frequency sensorineural hearing loss after undergoing translabyrinthine resection of a vestibular schwannoma. This resolved after a course of oral steroids. Seven years later, in 2010, the patient developed tumor recurrence. After retrosigmoid resection, the patient experienced a similar episode of transient, contralateral, low-frequency predominant sensorineural hearing loss.
CONCLUSION: The recurrence of contralateral hearing loss after craniotomies years apart suggests that patient specific anatomic risk factors predispose an individual to hearing loss after contralateral cerebellopontine angle surgery. Patients with previous history of contralateral hearing loss should be counseled that they may be at increased risk for recurrent loss in the setting of re-resection.

Entities:  

Mesh:

Year:  2013        PMID: 23921925     DOI: 10.1097/MAO.0b013e318298dedc

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  2 in total

1. 

Authors:  C Cassandro; P De Luca; M Ralli; F Gioacchini; F Di Berardino; A Albera; R Albera; E Cassandro; A Scarpa
Journal:  Transl Med UniSa       Date:  2019-01-12

Review 2.  Progression of Contralateral Hearing Loss in Patients with Unilateral Ear Involvement: A Scoping Review.

Authors:  Marzieh Amiri; Mahdieh Hasanalifard; Fakher Rahim; Alimohamad Asghari; Golshan Mirmomeni; Arash Bayat
Journal:  J Int Adv Otol       Date:  2022-09       Impact factor: 1.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.